
High-end Ophthalmic Medical Device R&D, Production, and Sales

Medical Device Media Reporting Pioneer
Share Professional Medical Device Knowledge
Just today,Shenzhen Certainn Technology Co., Ltd.(hereinafter referred to as "Moptim”)Announcement CompletedNearly 100 Million USD in Series B Financing. This round of financing was led byChina Venture Capital Co., Ltd.Leading investment, existing shareholdersCAS Investment, BV Baidu VenturesAdditional Investment Beyond the Requirement.
This round of funding will be used forIteration of underlying optical core technology, expansion of high-end intelligent manufacturing capacity, and upgrade of AI algorithms,And comprehensively promote the product inPrimary Healthcare in China and the Global MarketThe large-scale implementation, with hard-core technology assisting in the foundation-strengthening project of China's healthcare system, and promoting China's high-end ophthalmic devices to reach the global stage.
Invested Enterprise
Moptim:
Founded inIn 2003, it became a company integrating the research and development, production, sales, and service of high-end ophthalmic medical equipment.TheNational Key "Little Giant" Enterprise, National High-Tech Enterprise. It is the first approved ophthalmic product in ChinaMoptim is a company that produces OCT medical devices and achieves industrialization, successfully breaking the foreign technology monopoly. Its core products cover ophthalmic Optical Coherence Tomography (OCT), optical biometers, surgical microscopes, etc., with a sales network covering nearly 50 countries worldwide.
Lead Investment Institution
China Venture Capital:
Founded inIn 2000, it was initiated and established by the Central Committee of the China Democratic建国 Party, and is one of the important pioneers in China's local venture capital industry.The company's headquarters is located in Beijing, with investment coverage spanning all stages from angel investment to industry mergers and acquisitions. The focus is primarily on strategic emerging industries such as energy conservation and environmental protection, new materials, new energy, high-end manufacturing, and pharmaceuticals and medical care.Company's Own FundsRMB 500 million, managing two RMB funds with a combined scale of RMB 1.2 billion.Currently, the number of invested projects has exceeded300, assisting more than 50 enterprises in going public on capital markets both in China and abroad.
More exciting content
Welcome to follow WeChat Video Channel



BusinessBusiness cooperation email: qxzj@landianyiliao.com


